EFAVIRENZ
Clinical safety rating: avoid
Contraindicated (not allowed)
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Tablet 600 mg - Oral
Clinical note
Induces CYP3A4 and inhibits CYP2C9/CYP2C19 affecting many drugs Can cause severe psychiatric symptoms and rash.
dizziness
Loading safety data…